Categories
Weight Loss Products

Science or Snake Oil: is Garcinia cambogia the magic weight-loss pill it’s hyped up to be?

The burgeoning field of complementary medicines, including weight-loss products, is now a billion-dollar industry. Every year, more people are spending disposable income on complementary and alternative medicines that may prove to have no benefit for our health.

Garcinia Cambogia is one such example. Marketed as a weight-loss pill, it has had an exponential rise in sales since it was featured on the Doctor Oz show.

Garcinia cambogia is the former scientific name of a native Southeast Asian plant, belonging to the family Clusiaceae, that bears a pumpkin-shaped fruit. The skin of the fruit contains the active ingredient, hydroxycitric acid (HCA). HCA inhibits an enzyme that produces fatty acid, thus suppressing fatty acid and the processing of cholesterol.

But does this mode of action translate to the weight-loss claims associated with it? Or is it just clever marketing convincing us this product helps us lose weight?

An Australian advertisement for the weight-loss supplement Garcinia Cambogia.
Screenshot, http://www.garciniacambogiasave.com/, CC BY

Double-blinded, randomised controlled trials are the gold standard of clinical study and whenever possible should be conducted to test the effectiveness of a treatment compared to a placebo. Weight-loss products should be assessed for a minimum of six months, with a further six-month follow-up period (12 months total).

There has never been a long-term study investigating the efficacy of Garcinia Cambogia. Most of the studies have been conducted in animals.

In fact, the majority of well-designed trials investigating the effect of this product on weight loss have found no effect that is of clinical relevance. In a 12-week double-blind, placebo-controlled trial conducted in humans, people receiving 3000mg of Garcinia Cambogia extract (1500mg of the active component HCA) per day lost the same amount of weight as the control group.

Another 12-week study with a four-week follow-up (16 weeks total) also found no greater weight-loss effect than for a placebo control group. For those studies where a statistically significant effect was reported, the weight loss was around one kilogram more than for those receiving a placebo pill.

Positive and greater weight losses were found in some studies, but this effect is suppressed when looking at all of the studies combined.

The Garcinia Cambogia plant.
Livia Lacolare/Flickr, CC BY

With respect to other health benefits from taking this supplement, the evidence to suggest it can improve blood cholesterol levels is lacking.

Most importantly, the product safety profile of Garcinia Cambogia has been adequately tested and there appear to be no issues.

Some complementary medicines have been found to contribute to improved health outcomes, through increased efficacy and cost-effectiveness. However, if there is to be a role for such complementary and alternative weight-loss products and medicines, we must build upon the evidence to investigate whether these increasingly popular products are a viable treatment option.

A recent Obesity Australia and Price Waterhouse Coopers report found obesity cost Australia A$8.6 billion in 2011-2012, with the indirect costs far higher. We must establish whether complementary medicines have a role to play in preventing and treating obesity. If we take no action to reduce obesity rates, an additional 2.4 million people will become obese at a cost of $87.7 billion over 10 years.


Please visit this website if you’re interested in taking part in our clinical weight-loss trials on Garcinia Cambogia and other weight-loss supplements.

Categories
Weight Loss Products

FTC brings its first case against fake paid reviews on Amazon

The Federal Trade Commission announced on Tuesday evening that it has brought its first case against using fake reviews to sell products online. The Commission said it will settle with defendant Cure Encapsulations Inc., a New York City-based company, and owner Naftula Jacobwitz, who it accused of making false claims about a weight loss supplement and paying a third-party website to post fake reviews on Amazon.

Fake reviews are a constant nuisance for Amazon shoppers, despite algorithms designed to safeguard its review system, and the company has hit back with a series of lawsuits against websites that offer to post fake verified reviews.

According to the FTC’s complaint, Cure Encapsulations sold pills with garcinia cambogia, a tropical fruit also called brindleberry that is sometimes used as a “natural” weight loss aid. Called Quality Encapsulations Garcinia Cambogia, the pills were sold only on Amazon. Jacobwitz paid a website called www.amazonverifiedreviews.com to post favorable reviews in order to boost its rating.

An exhibit from the FTC’s complaint against Cure Encapsulations Inc.

On October 8, 2014, Jacobowitz sent an email to the site’s operator saying he’d pay a total of $1,000 for 30 reviews, three per day, with the goal of increasing its 4.2 rating to 4.3, which he claimed was necessary in order to have sales. He also wrote that he wanted the product to “stay a five star.” Www.amazonverifiedreviews.com then posted a series of fake five-star reviews praising the pills. The FTC said the reviews made false claims, including that the pills were a powerful appetite suppressant, caused weight loss of up to 20 pounds, and blocked the formation of new fat cells.

The proposed settlement includes a judgement of $12.8 million, to be suspended upon payment of $50,000 to the FTC and certain unpaid income tax obligations. The settlement also bans Cure Encapsulations and Jacobwitz from making weight-loss, fat-blocking, or disease-treatment claims for dietary supplements, food, or drugs, unless they have reliable scientific evidence from clinical trials in humans. They are also prohibited from making misrepresentations about endorsements, including fake reviews, and must tell Amazon which reviews were faked and email customers who have bought the pills to give them information about FTC’s allegations.

In press release, Andrew Smith, director of the FTC’s Bureau of Consumer Protection, said “When a company buys fake reviews to inflate its Amazon ratings, it hurts both shoppers and companies that play by the rules.”

In a statement to The Verge, an Amazon spokesperson said “We welcome the FTC’s work in this area. Amazon invests significant resources to protect the integrity of reviews in our store because we know customers value the insights and experiences shared by fellow shoppers. Even one inauthentic review is one too many. We have clear participation guidelines for both reviewers and selling partners and we suspend, ban, and take legal action on those who violate our policies.”

Categories
Weight Loss Products

Can NUTRAFUELS INC (OTCMKTS:NTFU)’s Tomorrow Be Different? The Stock Had Decline in Shorts | Thorold News

The stock of NUTRAFUELS INC (OTCMKTS:NTFU) registered a decrease of 32% in short interest. NTFU’s total short interest was 8,500 shares in February as published by FINRA. Its down 32% from 12,500 shares, reported previously. With 78,600 shares average volume, it will take short sellers 0 days to cover their NTFU’s short positions.

The stock increased 11.44% or $0.0195 during the last trading session, reaching $0.19. About 375,178 shares traded or 816.95% up from the average. NutraFuels, Inc. (OTCMKTS:NTFU) has 0.00% since February 24, 2018 and is . It has by 0.00% the SP500.

NutraFuels, Inc. manufactures and distributes oral spray nutritional and dietary products to retail and wholesale outlets. The company has market cap of $20.20 million. The companyÂ’s products include sleep spray to support a healthy sleep cycle and improve the quality of restful sleep; energize spray to enhance energy, and restore vigor and vitality; and garcinia cambogia spray, an appetite and weight management spray. It currently has negative earnings. It also offers NRG-X extreme energy spray to enhance energy and stamina; headache and pain spray to relieve headaches and pain; and hair, skin, and nails spray to nourish and encourage hair, skin, and nail growth.

More news for NutraFuels, Inc. (OTCMKTS:NTFU) were recently published by: Marketwired.com, which released: “NutraFuels (NTFU) Files its Application to Up List to the OTCQB OTC Market – Marketwired” on January 29, 2018. Globenewswire.com‘s article titled: “Freedom Leaf Inc. Announces National Distribution Agreement Other OTC:FRLF – GlobeNewswire” and published on February 28, 2018 is yet another important article.

Receive News Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.